Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Chiron  (Stock symbol: CHIR ) Acquired by Novartis (2005 $ 5,100,000,000 )

4560 Horton Street
Emeryville, CA 94608
USA
(510)-655-8730
Website Company Summary Management Team
Board

Outside board: (May no longer be on the board) Raymond Breu (Novartis AG CFO);  Vaughn D Bryson (Life Science Advisors);  Lewis W Coleman (Gordon & Betty Moore Foundation);  Pierre Douaze (Novartis Healthcare);  Richard Fredericks (U.S. Ambassador to Switzerland);  Paul Herrling (Novartis AG);  Denise O'Leary (Stanford Hospital & Clinics);  Edward E Penhoet (Gordon & Betty Ford Foundation);  Pieter J Strijkert (Crucell N.V.)
Former outside board: Gilbert Amelio (Sienna Ventures Sr. Partner);  William J Rutter (Synergenics);  Jack W Schuler (Stericycle)
Company

Business description: Chiron Corporation, headquartered in Emeryville, California, is a globapharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: biopharmaceuticals, vaccines and blood testing.
Customers include: American Red Cross;  Johnson and Johnson
Partners include: Genelabs TechnologiesSyntex;  Berlex;  Biocine;  Cetus;  CytoMed;  JandJ;  Ortho Pharmaceutical;  Pasteur Sanofi;  ZymeQuest
Capital

Ownership: Acquired by Novartis (2005 $ 5,100,000,000 )
Stock Symbol: CHIR

Last Tweets


 

Last Mentions


Overview
Record updated: Dec 2010
Sector: Biotech
Year Founded: 1981
Headcount: 4001-5000 as of Jan 2004
Ownership: Acquired by Novartis (2005 $ 5,100,000,000 )
Stock Symbol: CHIR